Controversy News
Most Popular Controversy Story
Congress: Were Enhance results secret?
Finally, someone asked the question we've been wanting to ask ourselves: Even if the Enhance study data remained blinded, could Merck or Schering-Plough have divined its overall sway? Sen. Charles... Read more...
Latest Headlines
- April 24, 2008
- March 27, 2008
- February 12, 2008
- February 4, 2008
- January 14, 2008
- December 7, 2007
- November 12, 2007
- November 2, 2007
- September 28, 2007
- September 4, 2007
- August 23, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
